共查询到16条相似文献,搜索用时 73 毫秒
1.
肖彭莹苑晓微 《中国微生态学杂志》2023,(7):817-820
目的 探究行辅助生殖技术(ART)反复着床失败患者应用乳酸菌阴道胶囊辅助治疗对子宫内膜容受性(ER)和阴道微生物的影响。方法选取2020年5月至2022年5月本院收治ART反复着床失败患者100例,根据治疗方式分为观察组(n=50)和对照组(n=50)。对照组采用常规治疗,观察组采用常规治疗联合乳酸菌阴道胶囊。比较两组的性激素水平(雌二醇、孕酮),内膜容积、子宫内膜厚度、血管血流指数(VFI)、内膜血流指数(FI)和阻力指数(RI)等子宫内膜容受性指标,阴道pH值、阴道菌群检出率和乳酸菌数量。结果 两组治疗前后血清雌二醇、孕酮水平比较,差异无统计学意义(P>0.05)。两组治疗前子宫内膜厚度、内膜容积、血管血流指数、内膜血流指数和阻力指数比较,差异无统计学意义(P>0.05)。治疗后观察组子宫内膜厚度、内膜容积和血管血流指数均高于治疗前(P<0.01)和对照组(P<0.05)。治疗前两组菌群检出率差异无统计学意义(P>0.05),治疗后两组菌群检出率均低于治疗前(P<0.05),治疗后观察组菌群检出率低于对照组(P<0.05)。两组阴道pH值均低于治疗前(P<0.001),治疗后观察组阴道pH值低于对照组(P<0.001)。两组阴道乳杆菌正常率均高于治疗前(P<0.05),治疗后观察组高于对照组(P<0.05)。两组胚胎着床率、临床妊娠率、早期流产率和持续妊娠率差异无统计学意义(P> 0.05)。结论 乳酸菌阴道胶囊治疗ART反复着床失败患者可以改善子宫内膜容受性和阴道菌群。 相似文献
2.
目的:观察电针结合红外线照射对反复着床失败(RIF)患者子宫内膜容受性、胚胎移植及妊娠情况的影响。方法:选取102例于2015年5月-2018年5月在我院行复苏胚胎移植的RIF患者,按照随机数字表法将患者分为电针结合红外线照射治疗组(A组,38例)、安慰针刺组(B组,34例)及空白对照组(C组,30例)。比较三组治疗前后血清雌二醇、孕酮水平,于治疗前后检测子宫内膜容受性超声学指标,包括子宫内膜厚度、内膜容积、血管血流指数(VFI)、内膜血流指数(FI)、阻力指数(RI),比较三组胚胎移植及妊娠情况。结果:三组治疗前后血清雌二醇、孕酮水平比较无统计学差异(P0.05)。治疗后A组子宫内膜厚度、内膜容积大于治疗前及B组、C组,VFI、FI高于治疗前及B组、C组,RI低于治疗前及B组、C组(P0.05)。三组移植胚胎数、生化妊娠率、临床妊娠率比较无统计学差异(P0.05),A组胚胎着床率高于B组、C组(P0.05)。结论:电针结合红外线照射治疗RIF患者可以改善子宫内膜容受性,提高胚胎着床率。 相似文献
3.
目的 探讨乳酸菌阴道胶囊对中晚期宫颈癌TP化疗患者血清IL 2、IL 10、TGF β1水平及阴道菌群的影响。 方法 选取2018年10月-2019年8月于本院接受TP化疗的83例中晚期宫颈癌患者为研究对象,以随机数字表法分为两组,观察组43例,对照组40例。两组均接受TP化疗,观察组在对照组基础上接受乳酸菌阴道胶囊治疗。比较两组临床疗效,治疗前后血清IL 2、IL 10、TGF β1水平,阴道菌群分布情况,致病微生物阳性检出率和化疗相关不良反应发生情况。 结果 两组临床疗效等级分布差异显著(P0.05)。 结论 乳酸菌阴道胶囊可提高中晚期宫颈癌TP化疗患者临床疗效,调节患者免疫应答水平,有效改善患者阴道菌群平衡,降低患者阴道致病微生物阳性率,安全性高。 相似文献
4.
孔瑶胡礼娟吴菲肖沁刘朝霞 《中国微生态学杂志》2023,(5):603-606
辅助生殖技术(assisted reproductive technology,ART)为许多不孕不育夫妇带来希望,尽管ART的技术在不断更新,但不孕症患者的临床妊娠率仍处于较低水平。随着“人类微生物组计划”及其他微生物宏基因组学和蛋白质组学等相关项目的开展,阴道微生物群与女性生殖道健康和疾病的研究引起了广泛讨论,并取得了大量成果。本文就阴道微生物群对不孕症及辅助生殖结局的影响进行了讨论和总结,并初步探讨阴道微生物群、生殖道黏膜免疫和子宫内膜容受性对辅助生殖结局的影响。 相似文献
5.
目的 探讨乳酸菌阴道胶囊干预对孕晚期细菌性阴道病(BV)患者阴道菌群及分娩结局的影响。方法 2017年12月‒2019年2月在泰山医学院附属青岛医院接受治疗及分娩的BV患者136例,参照随机数表法分为对照组、研究组各68例。对照组患者接受甲硝唑治疗,研究组患者接受乳酸菌阴道胶囊+甲硝唑治疗。持续1周后,对比两组患者的疗效、乳酸菌计数情况、用药不良反应发生情况的差异,记录两组患者分娩结局。结果 治疗1周后,两组患者的疗效分级差异有统计学意义(U=7.062、P=0.029);治疗总有效率的差异无统计学意义(2=2.030、P=0.154)。两组患者的阴道乳酸菌计数分级差异有统计学意义(U=9.179、P=0.047),研究组患者的乳酸菌计数正常率高于对照组患者(2=6.103、P=0.013)。用药期间,两组患者皮肤瘙痒、下腹疼痛、头晕头痛等不良反应发生率差异无统计学意义(2=0.341、1.007、0.208,P=0.559、0.316、0.649)。两组患者均无一例发生心律失常。研究组患者的胎膜早破、早产、产褥感染、子宫内膜炎发生率低于对照组患者(2=4.087、4.561、3.765、4.121,P=0.043、0.033、0.049、0.042)。两组患者的新生儿感染、新生儿高胆红素血症发生率差异无统计学意义(2=2.030、2.944,P=0.154、0.086)。结论 乳酸菌阴道胶囊干预对优化孕晚期BV患者阴道菌群、改善妊娠结局具有一定积极作用。 相似文献
6.
摘要:目的 系统评价乳酸菌阴道胶囊辅助治疗外阴阴道念珠菌病(VVC)的疗效及安全性。方法 计算机联机检索Cochrane图书馆、CNKI、VIP、万方数据库(各数据库检索时间为创建至2014年12月)中关于乳酸菌阴道胶囊辅助治疗VVC的随机对照试验(RCT),用RevMan 5.3软件对数据进行Meta分析。结果 共纳入18篇RCT,包括2 405例患者。Meta分析结果显示,乳酸菌阴道胶囊辅助治疗VVC效果优于对照组[RR=2.43,95%CI(1.98,2.98),P<0.00001]。结论 基于现有临床证据,乳酸菌阴道胶囊辅助治疗VVC有效,安全性高。但由于纳入研究数量较少,研究质量不统一,本结论尚需要更多大样本、高质量临床RCT予以证实。 相似文献
7.
目的系统评价乳酸菌阴道胶囊辅助治疗外阴阴道念珠菌病(VVC)的疗效及安全性。方法计算机联机检索CNKI、VIP、万方数据库(各数据库检索时间为创建至2014年12月)中关于乳酸菌阴道胶囊辅助治疗VVC的随机对照试验(RCT),用RevMan 5.3软件对数据进行Meta分析。结果共纳入18篇RCT,包括2 405例患者。Meta分析结果显示,乳酸菌阴道胶囊辅助治疗VVC效果优于对照组[OR=2.43,95%CI(1.98,2.98),P0.000 01]。结论基于现有临床证据,乳酸菌阴道胶囊辅助治疗VVC有效,安全性高。但由于纳入研究数量较少,研究质量不统一,本结论尚需要更多大样本、高质量临床RCT予以证实。 相似文献
8.
摘要 目的:探讨子宫内膜容受性检测(ERT)技术在反复种植失败患者冻融胚胎移植(FET)中的应用价值,并分析其临床妊娠的影响因素。方法:回顾性分析2019年10月~2022年4月期间海南省妇女儿童医学中心收治的150例反复种植失败患者的临床资料,根据是否接受ERT技术分为ERT组(n=78,接受ERT技术)和无ERT组(n=72,未接受ERT技术)。按照反复种植失败患者是否临床妊娠分为临床妊娠组和未临床妊娠组。采用单因素和多因素Logistic回归模型分析临床妊娠的影响因素。结果:两组异位妊娠率组间对比未见统计学差异(P>0.05)。ERT组临床妊娠率、活产率高于无ERT组,移植日内膜厚度大于无ERT组,移植胚胎数少于无ERT组,流产率低于无ERT组(P<0.05)。所有患者按照是否临床妊娠分为临床妊娠组(n=85)和未临床妊娠组(n=65)。单因素分析结果显示:临床妊娠与年龄、移植胚胎类别、移植胚胎数量、总周期数、FSH、子宫内膜厚度、子宫内膜类型有关(P<0.05),而与体质量指数(BMI)、不孕年限、不孕类型、胚胎冷冻保存时间无关(P>0.05)。多因素Logistic回归分析结果显示:年龄偏大、FSH偏高是临床妊娠的危险因素,而移植胚胎类别为囊胚、移植胚胎数量偏多是临床妊娠的保护因素(P<0.05)。结论:ERT技术用于反复种植失败患者FET中,可有效改善患者的临床妊娠。年龄、FSH、移植胚胎类别、移植胚胎数量是临床妊娠的影响因素。 相似文献
9.
周仙园 《中国微生态学杂志》2018,30(1)
目的 探讨乳酸菌阴道胶囊联合小剂量甲硝唑对中晚期妊娠滴虫性阴道炎妇女阴道菌群的调节作用。方法 选择中晚期妊娠滴虫性阴道炎妇女140例,随机分为观察组和对照组各70例。对照组妇女予以甲硝唑片0.2 g/次,3次/d,口服,连用1周。观察组在采用对照组治疗方法结束后再加用乳酸菌活菌胶囊0.25 g/次,1次/d,阴道放置,连用1周。治疗结束后2周复诊,比较两组妇女的临床疗效、阴道乳酸菌检出率及产H2O2阳性率。结果 观察组妇女临床总有效率明显高于对照组(χ2=4.52,P<0.05);观察组妇女阴道乳酸菌检出菌落≥1/2面积率明显高于对照组(χ2=60.51,P<0.01);观察组妇女产H2O2阳性率明显高于对照组(χ2=14.12,P<0.01)。结论 乳酸菌阴道胶囊联合小剂量甲硝唑治疗中晚期妊娠滴虫性阴道炎妇女的疗效确切,能明显升高阴道乳酸菌数量及活性,纠正阴道菌群紊乱。 相似文献
10.
目的 探讨乳酸菌阴道胶囊对菌群失调早产患者阴道菌群及分娩结局的影响.方法 2018年9月-2019年12月在龙华区人民医院接受治疗及分娩的菌群失调先兆早产患者80例,参照随机数表法分为对照组、研究组各40例.对照组患者接受硝呋太尔制霉素软胶囊治疗,研究组患者接受乳酸菌阴道胶囊治疗6d.停药1周后,比较两组患者的pH值、... 相似文献
11.
目的分析乳杆菌属细菌对宫颈上皮内瘤变(CIN)患者阴道菌群的影响,为该类患者的治疗提供参考。方法选择2019年1月至2020年1月我院收治的CIN患者137例,根据组织学病理结果分为CIN Ⅰ组(84例)和CIN Ⅱ、Ⅲ组(53例)。选择同期100例宫颈检查正常者为对照组。比较各组对象阴道菌群数量。根据患者阴道内乳杆菌数量将患者分为高数量组和低数量组,比较2组患者阴道菌群数量。结果CIN Ⅰ组患者阴道厚壁菌门数量低于CIN Ⅱ、Ⅲ组和对照组,而放线菌门数量高于CIN Ⅱ、Ⅲ组和对照组(均P<0.05)。CIN Ⅱ、Ⅲ组患者阴道乳杆菌属数量高于CIN Ⅰ组和对照组(均P<0.05)。CIN Ⅰ组患者阴道加德纳菌属、奇异菌属数量高于CIN Ⅱ、Ⅲ组和对照组(均P<0.05)。对照组对象阴道菌群Chao、ACE指数均低于CIN Ⅰ组和CIN Ⅱ、Ⅲ组(均P<0.05),同时CIN Ⅱ、Ⅲ组患者阴道菌群Chao、ACE指数均低于CIN Ⅰ组(均P<0.05)。高数量组患者阴道加德纳菌属、奇异菌属占比均低于低数量组(均P<0.05)。结论阴道中乳杆菌属数量的改变易影响阴道菌群,使其抗感染能力下降,增加女性CIN的风险。 相似文献
12.
《Reproductive biology》2021,21(4):100569
The successful implantation of the embryo into a receptive endometrium is essential for the establishment of a viable pregnancy while recurrent implantation failure (RIF) is a real challenge in assisted reproduction. The maternal innate immune system, specifically the Toll-like receptors (TLRs), are involved in maintaining immunity in the female reproductive tract (FRT) required for fertility. In this study, we aimed to investigate the importance of innate immunity-related gene expression in the regulation of human fertility and as a prediction of potential outcome of in vitro fertilization - embryo transfer (IVF-ET), thus, we assessed the gene expression levels of TLR signalling molecules using quantitative real-time PCR between endometrial biopsies of healthy fertile women, and the patients experiencing RIF. Interestingly, our results showed that, TRIB2 and TLR9 genes were differentially expressed between the endometrial biopsies of healthy women and those with RIF. However, comparing expression levels of same genes between pre-receptive and receptive healthy endometrial biopsies showed different genes (ICAM1, NFKBIA, VCAM1, LIF, VEGFB, TLR5) had significantly altered expression, suggesting their involvement in endometrial receptivity. Thus, further investigations will enable us to better understand the role of these genes in the biology of FRT and as a possible target for the improvement of infertility treatments and/or development of non-hormonal contraception. 相似文献
13.
Mingyang Li Jingwen Hu Lihua Yao Minzhi Gao 《Journal of cellular and molecular medicine》2020,24(18):10730-10743
Insufficient endometrial angiogenesis during peri‐implantation impairs endometrial receptivity (ER), which contributes to recurrent implantation failure (RIF) during in vitro fertilization and embryo transfer (IVF‐ET). Angiopoietin‐like protein 4 (ANGPTL4) acts as a multifunctional secretory protein and is involved in the regulation of lipid metabolism and angiogenesis in various tissues including the endometrium. Herein, we found decreased ANGPTL4 expression in endometrial tissue and serum during peri‐implantation period in 18 RIF‐affected women with elevated uterine arterial impedance (UAI) compared with the pregnancy controls. ANGPTL4 and peroxisome proliferator‐activated receptor gamma (PPARγ) expression were up‐regulated upon decidualization on human endometrial stromal cells (HESCs). Rosiglitazone promoted the expression of ANGPTL4 in HESCs and human umbilical vein endothelial cells (HUVECs) via PPARγ. ANGPTL4 promoted the proliferation, migration and angiogenesis of HUVECs in vitro. Our results suggest that decreased abundance of ANGPTL4 in endometrial tissues impairs the endometrial receptivity via restraining endometrial angiogenesis during decidualization; while rosiglitazone‐induced ANGPTL4 up‐regulation in hESCs and HUVECs through PPARγ. Therefore, ANGPTL4 could be a potential therapeutic approach for some RIF‐affected women with elevated UAI. 相似文献
14.
《Reproductive biology》2023,23(2):100733
ART is an important treatment method for infertile patients with endometriosis. However, the effects of endometriosis on embryo quality and endometrial receptivity remain unclear. Thus, we aimed to simultaneously investigate the impact of endometriosis and its stage on embryo quality and endometrial receptivity in women undergoing ART. We retrospectively analyzed the data from patients with and without endometriosis who underwent oocyte retrieval and/or high-quality embryos transfer between July 2015 and December 2020, including 1312 IVF cycles and 608 IVF or frozen-thawed embryo transfer (FET) cycles, respectively. The endometriosis group had a lower percentage of good cleavage-stage embryos and fertilization rates than those in the control group (p = 0.038 and 0.008, respectively). The number of retrieved oocytes, MII oocytes, cleavage, blastocysts, and blastulation rates was comparable between two groups. We found no significant difference in clinical pregnancy, implantation, live birth, miscarriage, or multiple pregnancy rates between the two groups among patients who transferred high-quality embryos. Stratification analysis showed that patients with stage III-IV endometriosis had fewer retrieved oocytes than those with stage I-II endometriosis (p = 0.012) and marginally fewer retrieved oocytes than the control group (p = 0.051). The stage I-II group had the lowest percentage of good cleavage-stage embryos, which was significantly lower than that of the control group (p = 0.043). In FET cycles, patients with stage III-IV endometriosis had a higher miscarriage rate than those in the control group (p = 0.023). Our results suggest that endometriosis does not alter endometrial receptivity but affects embryo quality, oocyte fertilization ability, and ovarian response. 相似文献
15.
Paula Renata Bueno Campos Canella Ricardo Barini Patrícia de Oliveira Carvalho Daniela Soares Razolli 《Journal of cellular and molecular medicine》2021,25(5):2290-2296
Altered immune and/or inflammatory response plays an important role in cases of recurrent pregnancy loss (RPL) and repeated implantation failure (RIF). Exacerbation of the maternal immune response through increased NK cell activity and inflammatory cytokines can cause embryo rejection leading to abortion or embryo implantation failure. Immunosuppressors or immunomodulators can help or prevent this condition. Currently, lipid emulsion therapy (LET) has emerged as a treatment for RPL and RIF in women with abnormal NK cell activity, by decreasing the exacerbated immune response of the maternal uterus and providing a more receptive environment for the embryo. However, the mechanisms by which the intralipid acts to reduce NK cell activity are still unclear. In this review, we focus on the studies that conducted LET to treat patients with RPL and RIF with abnormal NK cell activity. We find that although some authors recommend LET as an effective intervention, more studies are necessary to confirm its effectiveness in restoring NK cell activity to normal levels and to comprehend the underlying mechanisms of the lipids action in ameliorating the maternal environment and improving the pregnancy rate. 相似文献
16.
刘辉煌 《中国微生态学杂志》2020,32(2):207-210
目的 探讨乳酸菌阴道胶囊联合克霉唑治疗复发性外阴阴道假丝酵母菌病的效果及安全性。 方法 随机选择我院妇科于2017年7月-2018年12月收治的102例复发性外阴阴道假丝酵母菌病患者作为研究对象,共分为两组:单一克霉唑组和乳酸菌阴道胶囊与克霉唑联合组,每组各有51例患者,单一克霉唑组仅予以克霉唑阴道片治疗,而乳酸菌阴道胶囊与克霉唑联合组同时予以克霉唑及乳酸菌阴道胶囊治疗。比较两组患者症状好转率、临床治愈率、复发率和不良反应发生率。 结果 乳酸菌阴道胶囊与克霉唑联合组的症状好转率、临床治愈率高于单一克霉唑组,其疾病复发率低于单一克霉唑组(均P0.05)。 结论 乳酸菌阴道胶囊联合克霉唑治疗外阴阴道假丝酵母菌病的效果优于单一克霉唑组,并且两组患者不良反应发生率相当,即用药安全性相当,值得推广。 相似文献